These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 24510833)
41. Parasitic infection and the polarized Th2 immune response can alter a vaccine-induced immune response. Robinson TM; Nelson RG; Boyer JD DNA Cell Biol; 2003 Jun; 22(6):421-30. PubMed ID: 12906735 [TBL] [Abstract][Full Text] [Related]
42. Evolution of electroporated DNA vaccines. Keane-Myers AM; Bell M Methods Mol Biol; 2014; 1121():269-78. PubMed ID: 24510831 [TBL] [Abstract][Full Text] [Related]
43. Electroporation delivery of DNA vaccines: prospects for success. Sardesai NY; Weiner DB Curr Opin Immunol; 2011 Jun; 23(3):421-9. PubMed ID: 21530212 [TBL] [Abstract][Full Text] [Related]
44. Adipose tissue: a new target for electroporation-enhanced DNA vaccines. Fisher PD; Brambila CJ; McCoy JR; Kiosses WB; Mendoza JM; Oh J; Yung BS; Schultheis K; Smith TRF; Broderick KE Gene Ther; 2017 Dec; 24(12):757-767. PubMed ID: 29106403 [TBL] [Abstract][Full Text] [Related]
46. DNA vaccines: prime time is now. Gary EN; Weiner DB Curr Opin Immunol; 2020 Aug; 65():21-27. PubMed ID: 32259744 [TBL] [Abstract][Full Text] [Related]
47. The diversity of HIV-1 fights against vaccine efficacy: how self-assembling protein nanoparticle technology may fight back. Karch CP; Burkhard P; Matyas GR; Beck Z Nanomedicine (Lond); 2021 Apr; 16(8):673-680. PubMed ID: 33715403 [TBL] [Abstract][Full Text] [Related]
48. HIV-1 vaccine--many miles to go before we sleep. Jeang KT; Huang LM J Formos Med Assoc; 2009 Nov; 108(11):827-9. PubMed ID: 19933024 [No Abstract] [Full Text] [Related]
49. Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments. Bodles-Brakhop AM; Heller R; Draghia-Akli R Mol Ther; 2009 Apr; 17(4):585-92. PubMed ID: 19223870 [TBL] [Abstract][Full Text] [Related]
50. DNA vaccines: progress and challenges. Donnelly JJ; Wahren B; Liu MA J Immunol; 2005 Jul; 175(2):633-9. PubMed ID: 16002657 [TBL] [Abstract][Full Text] [Related]
52. Production of research-grade antibody by in vivo electroporation of DNA-encoding target protein. Okahara F; Itoh K; Ebihara M; Kobayashi M; Maruyama H; Kanaho Y; Maehama T Anal Biochem; 2005 Jan; 336(1):138-40. PubMed ID: 15582570 [No Abstract] [Full Text] [Related]
53. DNA vaccines: ready for prime time? Kutzler MA; Weiner DB Nat Rev Genet; 2008 Oct; 9(10):776-88. PubMed ID: 18781156 [TBL] [Abstract][Full Text] [Related]
54. Introduction to fourth special issue on electroporation-based technologies and treatments. Miklavčič D; Mir LM; Vernier PT J Membr Biol; 2014 Dec; 247(12):1207-8. PubMed ID: 25359202 [No Abstract] [Full Text] [Related]
55. Promising HIV vaccines could stall without coordinated research. Maxmen A Nature; 2018 Mar; 555(7694):17-18. PubMed ID: 32094904 [No Abstract] [Full Text] [Related]